Project Grant R01HL173976
Award Date
12/16/24
Completion Date
11/30/28
Dollars Obligated
$1.4M
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
This $1,981,077 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research investigating the molecular mechanisms underlying the circadian regulation of cardiac ion channels and electrophysiology. The project aims to elucidate how circadian alignment and misalignment impact the transcription, translation, and physiological function of genes essential for normal cardiac activity. Key...
This Project Grant award, with Assistance Type of $143,829.00, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The primary objective is to establish human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) as robust models for mechanistic studies of how intrinsic circadian regulation impacts cardiomyocyte size and function. The research aims to determine whether mutations that impact cellular...
This $777,497 federal Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will support research at The Washington University to investigate how the circadian clock mediates the adult-age, pro-resolution response to viral asthma triggers.
The research aims to clarify how the circadian clock within alveolar macrophages and airway epithelial cells promotes the resolution of viral inflammation and normal...
The Washington University Office of Sponsored Research Services Division was awarded a $311,000 Project Grant under the National Institute on Aging's Aging Research program (CFDA 93.866) to determine temporal links between changes in circadian rhythms, systemic inflammation, and delirium severity in older adults undergoing elective cardiac surgery. The research aims to establish the clinical relevance of molecular circadian rhythm disruptions during the perioperative period and shift delirium...
This $2,803,961 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports a research project titled "Integrated Mechanisms of Primary and Chronic Graft Dysfunction Following Lung Transplantation" at Northwestern University.
The research aims to investigate the complex interplay between immune responses and lung tissue damage that underlie primary graft dysfunction (PGD) and chronic lung...
This $415,134 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) aims to develop advanced mathematical techniques for modeling and controlling the dynamics of complex biological networks, with a focus on understanding and engineering circadian rhythms.
The primary objectives are to: 1) Create a "Moment Kernel Machine" (MKM) modeling framework that can accurately represent nonlinear...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $798,958 to Northwestern University to conduct research on the molecular mechanisms linking primary graft dysfunction (PGD) and chronic lung allograft dysfunction (CLAD) after lung transplantation.
The key objectives are to determine whether activation of the integrated stress response (ISR) in the airway and alveolar...
This federal Project Grant award of $821,982 was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The grant aims to investigate variability in sleep timing as a potential new risk factor for cardiovascular disease (CVD) among women, with a focus on determining differences associated with ethnicity and menopausal status, as well as examining the potential mediating role of caregiving, stress, and depression. The...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $3,220,474 to New York University School of Medicine to optimize the allocation of heart transplants from deceased donors. The key objectives are to:
Analyze disparities in heart transplant access, including for candidates who are sensitized, have different sizes, or are of different races/ethnicities.
Develop a machine...
This federal Project Grant award of $799,354, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to comprehensively understand and pharmacologically target the necroptotic pathways in both the donor and recipient lungs to reduce the incidence of primary graft dysfunction (PGD) in lung transplant recipients.
The key research activities supported by this grant include: 1) Exploring the role of TNF-α-induced...